The next-generation peptide synthesised with NL-PEPTIDES technology is encapsulated in an enteral capsule made with NL-PEPTIDES TM DELIVERY technology.
The swallowed capsule enters the small intestine intact.
The first capsule is dissolved in the small intestine. A protease enzyme inhibitor is released - (yellow), which creates a favourable environment for the uptake of the peptide by lowering its pH to min. 5.5.
The second capsule is dissolved. The active ingredient - peptide - (blue colour) and peptide absorption enhancer acyl carnitine (green colour) are released. The peptide is absorbed into the body.